These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 20473062

  • 1. Two-year outcome of vagus nerve stimulation in treatment-resistant depression.
    Bajbouj M, Merkl A, Schlaepfer TE, Frick C, Zobel A, Maier W, O'Keane V, Corcoran C, Adolfsson R, Trimble M, Rau H, Hoff HJ, Padberg F, Müller-Siecheneder F, Audenaert K, van den Abbeele D, Matthews K, Christmas D, Eljamel S, Heuser I.
    J Clin Psychopharmacol; 2010 Jun; 30(3):273-81. PubMed ID: 20473062
    [Abstract] [Full Text] [Related]

  • 2. Vagus nerve stimulation for depression: efficacy and safety in a European study.
    Schlaepfer TE, Frick C, Zobel A, Maier W, Heuser I, Bajbouj M, O'Keane V, Corcoran C, Adolfsson R, Trimble M, Rau H, Hoff HJ, Padberg F, Müller-Siecheneder F, Audenaert K, Van den Abbeele D, Stanga Z, Hasdemir M.
    Psychol Med; 2008 May; 38(5):651-61. PubMed ID: 18177525
    [Abstract] [Full Text] [Related]

  • 3. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.
    Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, Lavori P, Howland R, Kling MA, Rittberg B, Carpenter L, Ninan P, Moreno F, Schwartz T, Conway C, Burke M, Barry JJ.
    Biol Psychiatry; 2005 Sep 01; 58(5):355-63. PubMed ID: 16139581
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.
    Cristancho P, Cristancho MA, Baltuch GH, Thase ME, O'Reardon JP.
    J Clin Psychiatry; 2011 Oct 01; 72(10):1376-82. PubMed ID: 21295002
    [Abstract] [Full Text] [Related]

  • 5. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.
    George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, Howland R, Kling MA, Moreno F, Rittberg B, Dunner D, Schwartz T, Carpenter L, Burke M, Ninan P, Goodnick P.
    Biol Psychiatry; 2005 Sep 01; 58(5):364-73. PubMed ID: 16139582
    [Abstract] [Full Text] [Related]

  • 6. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
    Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, Howland R, Kling MA, Rittberg BR, Burke WJ, Rapaport MH, Zajecka J, Nierenberg AA, Husain MM, Ginsberg D, Cooke RG.
    Biol Psychiatry; 2005 Sep 01; 58(5):347-54. PubMed ID: 16139580
    [Abstract] [Full Text] [Related]

  • 7. Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression.
    Burke MJ, Husain MM.
    J ECT; 2006 Sep 01; 22(3):218-22. PubMed ID: 16957540
    [Abstract] [Full Text] [Related]

  • 8. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders.
    George MS, Ward HE, Ninan PT, Pollack M, Nahas Z, Anderson B, Kose S, Howland RH, Goodman WK, Ballenger JC.
    Brain Stimul; 2008 Apr 01; 1(2):112-21. PubMed ID: 20633378
    [Abstract] [Full Text] [Related]

  • 9. A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.
    Aaronson ST, Sears P, Ruvuna F, Bunker M, Conway CR, Dougherty DD, Reimherr FW, Schwartz TL, Zajecka JM.
    Am J Psychiatry; 2017 Jul 01; 174(7):640-648. PubMed ID: 28359201
    [Abstract] [Full Text] [Related]

  • 10. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.
    J Affect Disord; 2009 Jun 01; 115(3):439-49. PubMed ID: 19027961
    [Abstract] [Full Text] [Related]

  • 11. Vagus nerve stimulation in treatment-resistant depression: acute and follow-up results of an italian case series.
    Dell'Osso B, Oldani L, Palazzo MC, Balossi I, Ciabatti M, Altamura AC.
    J ECT; 2013 Mar 01; 29(1):41-4. PubMed ID: 23303420
    [Abstract] [Full Text] [Related]

  • 12. P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder.
    Neuhaus AH, Luborzewski A, Rentzsch J, Brakemeier EL, Opgen-Rhein C, Gallinat J, Bajbouj M.
    J Affect Disord; 2007 Jun 01; 100(1-3):123-8. PubMed ID: 17098290
    [Abstract] [Full Text] [Related]

  • 13. Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery.
    Elliott RE, Carlson C, Kalhorn SP, Moshel YA, Weiner HL, Devinsky O, Doyle WK.
    Epilepsy Behav; 2009 Nov 01; 16(3):454-60. PubMed ID: 19767244
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of vagus nerve stimulation over time: review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS > 10 years.
    Elliott RE, Morsi A, Tanweer O, Grobelny B, Geller E, Carlson C, Devinsky O, Doyle WK.
    Epilepsy Behav; 2011 Mar 01; 20(3):478-83. PubMed ID: 21296622
    [Abstract] [Full Text] [Related]

  • 15. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression.
    Sackeim HA, Keilp JG, Rush AJ, George MS, Marangell LB, Dormer JS, Burt T, Lisanby SH, Husain M, Cullum CM, Oliver N, Zboyan H.
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan 01; 14(1):53-62. PubMed ID: 11234909
    [Abstract] [Full Text] [Related]

  • 16. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S, Ferreri M, Cabanac F, Bitton M.
    Encephale; 2003 Jan 01; 29(5):438-44. PubMed ID: 14615693
    [Abstract] [Full Text] [Related]

  • 17. The application of vagus nerve stimulation and deep brain stimulation in depression.
    Mohr P, Rodriguez M, Slavíčková A, Hanka J.
    Neuropsychobiology; 2011 Jan 01; 64(3):170-81. PubMed ID: 21811087
    [Abstract] [Full Text] [Related]

  • 18. Clinical benefits and cost effectiveness of vagus nerve stimulation in a long-term treatment of patients with major depression.
    Sperling W, Reulbach U, Kornhuber J.
    Pharmacopsychiatry; 2009 May 01; 42(3):85-8. PubMed ID: 19452375
    [Abstract] [Full Text] [Related]

  • 19. Cumulative effect of vagus nerve stimulators on intractable seizures observed over a period of 3years.
    Siddiqui F, Herial NA, Ali II.
    Epilepsy Behav; 2010 Jul 01; 18(3):299-302. PubMed ID: 20580901
    [Abstract] [Full Text] [Related]

  • 20. Changes in gustatory perceptions of patients with major depression treated with vagus nerve stimulation (VNS).
    Sperling W, Biermann T, Spannenberger R, Clepce M, Padberg F, Reulbach U, Kornhuber J, Thuerauf N.
    Pharmacopsychiatry; 2011 Mar 01; 44(2):67-71. PubMed ID: 21157695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.